Lataa...
Emerging methods for disease monitoring in malignant gliomas
MRI remains the backbone of measuring disease burden and treatment response in individuals with malignant gliomas. Traditional radiographic approaches, however, are largely limited to depicting anatomic changes and are not a direct measure of disease burden. For example, contrast enhancement is rela...
Tallennettuna:
| Julkaisussa: | CNS Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Future Medicine Ltd
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4986516/ https://ncbi.nlm.nih.gov/pubmed/25054821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.13.44 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|